Visioneering Technologies, Inc Share Price and Company Fundamentals
Last traded: Today at 1:24 AM
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. It offers NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
|Primary activities||Design, sale and distribution of NaturalVueTM contact lenses.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||10745 Westside Way Suite 200 Alpharetta GA 30009 United States|
|Phone / Fax||844 884 5367 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Visioneering Technologies, Inc does not pay dividends.
As of May 2021, following are the company executives and directors listed on Visioneering Technologies, Inc.
|Dr. Stephen Snowdy||CEO & Exec. Director||50||498.98k|
|Mr. Brian D. Lane CPA||Chief Financial Officer||58||328.07k|
|Mr. Tony Sommer Jr.||Sr. VP of Sales & Marketing||316.64k|
|Dr. Richard A. Griffin||Founder & Medical Adviser|
|Ms. Leanne Ralph BBus, ACIS, AAICD||Company Sec.|
|Ms. Layna L. Mendlinger||Exec. Director of Marketing|
|Dr. Douglas P. Benoit OD, FAAO||Exec. Director of Professional Affairs|
Profitability and management effectiveness
Return on assets
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Visioneering Technologies, Inc is 33.09M and its enterprise value is 16.56M. The enterprise value to revenue ratio of VTI is 3.24.
The VTI's stocks Beta value is 1.75 making it 75% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Visioneering Technologies, Inc (VTI)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Visioneering Technologies, Inc (ASX:VTI) Frequently Asked Questions
1. What is Visioneering Technologies, Inc's Stock Symbol?
Visioneering Technologies, Inc trades on ASX under the ticker symbol "VTI".
2. What is Visioneering Technologies, Inc's stock price today?
One share of VTI stock can currently be purchased for approximately $0.014.
3. How can I contact Visioneering Technologies, Inc?
Visioneering Technologies, Inc's mailing address is 10745 Westside Way Suite 200 Alpharetta GA 30009 United States. The company can be reached via phone at 844 884 5367.
4. What is Visioneering Technologies, Inc's official website?
The official website of Visioneering Technologies, Inc is http://vtivision.com.
5. Which share registry manages Visioneering Technologies, Inc's stock?
Visioneering Technologies, Inc's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.